Clinical Trial Update: ASCs in Recently Diagnosed Non-ischemic Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating adipose-derived stem cells for non-ischemic heart failure with reduced ejection fraction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Adipose-Derived Stem Cells (adipose-derived stem cells)

Snippet

Sponsor: Cell to Cure ApS | Conditions: Non-Ischemic Heart Failure, Reduced Ejection Fraction Heart Failure | Phase 2 | Status: WITHDRAWN